UBS ASSET MANAGEMENT AMERICAS LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,124,862
-20.3%
402,898
-3.2%
0.00%
-33.3%
Q2 2023$6,431,9270.0%416,3060.0%0.00%0.0%
Q1 2023$6,431,927
+991.6%
416,306
+1058.0%
0.00%
Q4 2022$589,236
-99.9%
35,951
-31.7%
0.00%
-100.0%
Q3 2022$973,786,000
+46.6%
52,637
+4.2%
0.00%
Q2 2022$664,220,000
+60.4%
50,511
+13.1%
0.00%
Q1 2022$414,129,000
-5.1%
44,6740.0%0.00%
Q4 2021$436,465,000
-96.4%
44,674
-87.5%
0.00%
-100.0%
Q3 2021$12,152,028,000
-15.5%
357,623
-9.0%
0.01%
-16.7%
Q2 2021$14,386,925,000
+12.3%
392,978
+37.5%
0.01%0.0%
Q1 2021$12,815,318,000
-42.2%
285,801
-26.4%
0.01%
-40.0%
Q4 2020$22,155,201,000
+52.4%
388,211
+37.0%
0.01%
+25.0%
Q3 2020$14,537,857,000
-10.1%
283,389
+4.7%
0.01%
-20.0%
Q2 2020$16,166,980,000
+38.6%
270,713
-4.5%
0.01%
+25.0%
Q1 2020$11,667,661,000
-39.9%
283,402
-9.1%
0.01%
-33.3%
Q4 2019$19,402,946,000
+151.8%
311,744
+37.3%
0.01%
+140.0%
Q3 2019$7,704,346,000226,9990.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders